Journal for ImmunoTherapy of Cancer (Nov 2023)
816 NT-I7 and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that favors anti-tumor efficacy in combination with checkpoint inhibitors
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)